Abstract
Can prevention models now common to medicine be extended to psychotic disorders? Advances in early detection and intervention in cardiovascular disease, diabetes, and cancer have led to substantial reductions in morbidity and mortality and improved quality of life among individuals with these conditions (Adams et al. 2007; Berenson 2005; Parekh et al. 2006; Peters et al. 1996). The success of these programs is based on four primary factors: (1) they target disorders with relatively high prevalence; (2) risk is known to be greatest among particular demographic groups, facilitating efficiency of screening; (3) accurate and objective assessment methods exist for early detection; and (4) an array of interventions are available that scale in invasiveness with stage of illness.
Chapter in W.F. Gattaz & G.F. Busatto (eds.), Search for the Causes of Schizophrenia, Vol. VI, Springer Verlag, New York.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams, E.K., Breen, N., and Joski, P.J. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and pap test utilization among white, Hispanic, and African American women: 1996–2000. Cancer, 109(2 Suppl):348–58, 2007.
Addington, J., Cadenhead, K.S., Cannon, T.D., Cornblatt, B., McGlashan, T.H., Perkins, D.O., Seidman, L.J., Tsuang, M., Walker, E.F., Woods, S.W., and Heinssen, R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull, 33(3):665–72, 2007.
Arseneault, L., Cannon, M., Witton, J., and Murray, R.M. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry, 184:110–7, 2004.
Berenson, G.S. Obesity – a critical issue in preventive cardiology: the Bogalusa Heart Study. Prev Cardiol, 8(4):234–41, quiz 242–3, 2005.
Borgwardt, S.J., Riecher-Rossler, A., Dazzan, P., Chitnis, X., Aston, J., Drewe, M., Gschwandtner, U., Haller, S., Pfluger, M., Rechsteiner, E., D’Souza, M., Stieglitz, R.D., Radu, E.W., and McGuire, P.K. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry, 61(10):1148–56, 2007.
Buckholtz, J.W., Meyer-Lindenberg, A., Honea, R.A., Straub, R.E., Pezawas, L., Egan, M.F., Vakkalanka, R., Kolachana, B., Verchinski, B.A., Sust, S., Mattay, V.S., Weinberger, D.R., and Callicott, J.H. Allelic variation in RGS4 impacts functional and structural connectivity in the human brain. J Neurosci, 27(7):1584–93, 2007.
Cannon, T.D., Cadenhead, K., Cornblatt, B., Woods, S.W., Addington, J., Walker, E., Seidman, L.J., Perkins, D., Tsuang, M., McGlashan, T., and Heinssen, R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry, 65(1):28–37, 2008.
Cannon, T.D., Hennah, W., van Erp, T.G., Thompson, P.M., Lonnqvist, J., Huttunen, M., Gasperoni, T., Tuulio-Henriksson, A., Pirkola, T., Toga, A.W., Kaprio, J., Mazziotta, J., and Peltonen, L. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry, 62(11):1205–13, 2005.
Cannon, T.D., Thompson, P.M., van Erp, T.G., Toga, A.W., Poutanen, V.P., Huttunen, M., Lonnqvist, J., Standerskjold-Nordenstam, C.G., Narr, K.L., Khaledy, M., Zoumalan, C.I., Dail, R., and Kaprio, J. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci USA, 99:3228–33, 2002a.
Cannon, T.D., van Erp, T.G., Bearden, C.E., Loewy, R., Thompson, P., Toga, A.W., Huttunen, M.O., Keshavan, M.S., Seidman, L.J., and Tsuang, M.T. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull, 29:653–69, 2003.
Cannon, T.D., van Erp, T.G., Huttunen, M., Lönnqvist, J., Salonen, O., Valanne, L., Poutanen, V.P., Standertskjöld-Nordenstam, C.G., Gur, R.E., and Yan, M. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry, 55(12):1084–91, 1998.
Cannon, T.D., van Erp, T.G., Rosso, I.M., Huttunen, M., Lonnqvist, J., Pirkola, T., Salonen, O., Valanne, L., Poutanen, V.P., and Standertskjold-Nordenstam, C.G. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry, 59(1):35–41, 2002b.
Cornblatt, B.A., Lencz, T., Smith, C.W., Correll, C.U., Auther, A.M., and Nakayama, E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull, 29(4):633–51, 2003.
Dazzan, P., Morgan, K.D., Orr, K., Hutchinson, G., Chitnis, X., Suckling, J., Fearon, P., McGuire, P.K., Mallett, R.M., Jones, P.B., Leff, J., and Murray, R.M. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology, 30:765–74, 2005.
Feinberg, I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res, 17(4):319–34, 1982.
Ford, J.M., and Mathalon, D.H. Corollary discharge dysfunction in schizophrenia: can it explain auditory hallucinations? Int J Psychophysiol, 58(2–3):179–89, 2005.
Ford, J.M., Mathalon, D.H., Whitfield, S., Faustman, W.O., and Roth, W.T. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol Psychiatry, 51(6):485–92, 2002.
Glantz, L.A., and Lewis, D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry, 57(1):65–73, 2000.
Grenander, U., and Miller, M.I. Computational anatomy: an emerging discipline. Q Appl Math, 4:617–94, 1998.
Gross, G., and Huber, G. Psychopathology of basic stages of schizophrenia in view of formal thought disturbances. Psychopathology, 18(2–3):115–25, 1985.
Gur, R.E., Cowell, P., Turetsky, B.I., Gallacher, F., Cannon, T., Bilker, W., and Gur, R.C. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry, 55:145–52, 1998.
Hafner, H. Onset and course of the first schizophrenic episode. Kao-Hsiung i Hsueh Ko Hsueh Tsa Chih [kaohsiung Journal of Medical Sciences], 14(7):413–31, 1998.
Haroun, N., Dunn, L., Haroun, A., and Cadenhead, K.S. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull, 32(1):166–78, 2006.
Harrison, P.J., and Weinberger, D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry, 10(1):40–68, image 5, 2005.
Ho, B.C. MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms. Schizophr Res, 96(1–3):1–13, 2007.
Ho, B.C., Andreasen, N.C., Nopoulos, P., Arndt, S., Magnotta, V., and Flaum, M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry, 60:585–94, 2003.
Hoffman, R.E., and McGlashan, T.H. Parallel distributed processing and the emergence of schizophrenic symptoms. Schizophr Bull, 19(1):119–40, 1993.
Hoffman, R.E., and McGlashan, T.H. Neural network models of schizophrenia. Neuroscientist, 7(5):441–54, 2001.
Holmes, A.P., Blair, R.C., Watson, J.D., and Ford, I. Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab, 16(1):7–22, 1996.
Huttenlocker, P.R. Synaptic density in the human frontal cortex – developmental changes and effects of aging. Brain Res, 163:195–205, 1979.
Huttenlocker, P.R., and Dabhokar, A.S. Regional differences in synaptogenesis in human cerebral cortex. J Comparative Neurol, 387:167–78, 1997.
Insel, T.R., and Scolnick, E.M. Cure therapeutics and strategic prevention: raising the bar for mental health research. Mol Psychiatry, 11(1):11–7, 2006.
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J.E., Day, R., and Bertelsen, A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl, 20:1–97, 1992.
Jacobsen, L.K., Giedd, J.N., Castellanos, F.X., Vaituzis, A.C., Hamburger, S.D., Kumra, S., Lenane, M.C., and Rapoport, J.L. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry, 155(5):678–85, 1998.
Job, D.E., Whalley, H.C., Johnstone, E.C., and Lawrie, S.M. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage, 25:1023–30, 2005.
Job, D.E., Whalley, H.C., McIntosh, A.M., Owens, D.G.C., Johnstone, E.C., and Lawrie, S.M. Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Medicine, 4:29, 2006.
Karlsgodt, K.H., Sun, D., Jimenez, A.M., Lutkenhoff, E.S., Willhite, R., van Erp, T.G., and Cannon, T.D. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol, 20(4):1297–327, 2008.
Keshavan, M.S., Anderson, S.A., and Pettegrew, J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res, 28(3):239–65, 1994.
Keshavan, M.S., Haas, G., Miewald, J., Montrose, D.M., Reddy, R., Schooler, N.R., and Sweeney, J.A. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull, 29(4):757–69, 2003.
Kirkbride, J.B., Fearon, P., Morgan, C., Dazzan, P., Morgan, K., Tarrant, J., Lloyd, T., Holloway, J., Hutchinson, G., Leff, J.P., Mallett, R.M., Harrison, G.L., Murray, R.M., and Jones, P.B. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry, 63(3):250–8, 2006.
Klosterkotter, J., Hellmich, M., Steinmeyer, E.M., and Schultze-Lutter, F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry, 58(2):158–64, 2001.
Kristensen, K., and Cadenhead, K.S. Cannabis Abuse and Risk for Psychosis in a Prodromal Sample. Psychiatry Res, 151(1–2):151–4, 2007.
Lencz, T., Smith, C.W., Auther, A.M., Correll, C.U., and Cornblatt, B.A. The assessment of “prodromal schizophrenia”: unresolved issues and future directions. Schizophr Bull, 29(4):717–28, 2003.
Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., Keefe, R.S., Davis, S.M., Davis, C.E., Lebowitz, B.D., Severe, J., and Hsiao, J.K. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med, 353(12):1209–23, 2005a.
Lieberman, J.A., Tollefson, G.D., Charles, C., Zipursky, R., Sharma, T., Kahn, R.S., Keefe, R.S., Green, A.I., Gur, R.E., McEvoy, J., Perkins, D., Hamer, R.M., Gu, H., and Tohen, M. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry, 62(4):361–70, 2005b.
Loewy, R.L., Johnson, J.K., and Cannon, T.D. Self-report of attenuated psychotic experiences in a college population. Schizophr Res, 93(1–3):144–51, 2007.
Malla, A.K., Norman, R.M., Manchanda, R., Ahmed, M.R., Scholten, D., Harricharan, R., Cortese, L., and Takhar, J. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophr Res, 54(3):231–42, 2002.
Mathalon, D.H., Rapoport, J.L., Davis, K.L., and Krystal, J.H. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry. Arch Gen Psychiatry, 60:846–8, 2003.
McGlashan, T.H. Duration of untreated psychosis in first-episode schizophrenia: marker or determinant of course? Biol Psychiatry, 46(7):899–907, 1999.
McGlashan, T.H., and Hoffman, R.E. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry, 57:637–48, 2000.
McGlashan, T.H., and Johannessen, J.O. Early detection and intervention with schizophrenia: Rationale. Schizophr Bull, 22(2):201–22, 1996.
McGlashan, T.H., Zipursky, R.B., Perkins, D., Addington, J., Miller, T., Woods, S.W., Hawkins, K.A., Hoffman, R.E., Preda, A., Epstein, I., Addington, D., Lindborg, S., Trzaskoma, Q., Tohen, M., and Breier, A. Randomized double-blind clinical trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry, 163:790–9, 2006.
McGorry, P.D., Yung, A.R., and Phillips, L.J. The “close-in” or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull, 29:771–90, 2003.
McGorry, P.D., Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S., Cosgrave, E.M., Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S., and Jackson, H. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry, 59(10):921–8, 2002.
Miller, T.J., McGlashan, T.H., Rosen, J.L., Cadenhead, K., Ventura, J., McFarlane, W., Perkins, D.O., Pearlson, G.D., and Woods, S.W. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull, 29(4):703–15, 2003.
Miller, T.J., McGlashan, T.H., Rosen, J.L., Somjee, L., Markovich, P.J., Stein, K., and Woods, S.W. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry, 159(5):863–5, 2002.
Owens, D.G., Miller, P., Lawrie, S.M., and Johnstone, E.C. Pathogenesis of schizophrenia: a psychopathological perspective. Br J Psychiatry, 186:386–93, 2005.
Pantelis, C., Velakoulis, D., McGorry, P.D., Wood, S.J., Suckling, J., Phillips, L.J., Yung, A.R., Bullmore, E.T., Brewer, W., Souldsby, B., Desmond, P., and McGuire, P.K. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet, 361:281–8, 2003.
Parekh, D.J., Ankerst, D.P., Higgins, B.A., Hernandez, J., Canby-Hagino, E., Brand, T., Troyer, D.A., Leach, R.J., and Thompson, I.M. External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population. Urology, 68(6):1152–5, 2006.
Peters, A.L., Davidson, M.B., Schriger, D.L., and Hasselblad, V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA, 276(15):1246–52, 1996.
Phillips, L.J., Velakoulis, D., Pantelis, C., Wood, S., Yuen, H.P., Yung, A.R., Desmond, P., Brewer, W., and McGorry, P.D. Non-reduction in hippocampal volume is associated with higher risk of psychosis. Schizophr Res, 58(2–3):145–58, 2002.
Prasad, K.M., Chowdari, K.V., Nimgaonkar, V.L., Talkowski, M.E., Lewis, D.A., and Keshavan, M.S. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry, 10(2):213–9, 2005.
Preti, A. Fetal hypoxia, genetic risk, and schizophrenia. Am J Psychiatry, 160(6):1186, author reply 1186, 2003.
Rosen, J.L., Miller, T.J., D’Andrea, J.T., McGlashan, T.H., and Woods, S.W. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. Schizophr Res, 85(1–3):124–31, 2006.
Saha, S., Chant, D., and McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry, 64(10):1123–31, 2007.
Saha, S., Chant, D., Welham, J., and McGrath, J. A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2(5):e141, 2005.
Schreiber, H., Baur-Seack, K., Kronhuber, H.H., Wallner, B., Friedrich, J.M., De Winter, I.M., and Born, J. Brain morphology in adolescents at genetic risk for schizophrenia assessed by qualitative and quantitative magnetic resonance imaging. Schizophr Res, 40(1):81–4, 1999.
Schwartz-Stav, O., Apter, A., and Zalsman, G. Depression, suicidal behavior and insight in adolescents with schizophrenia. Eur Child Adolesc Psychiatry, 15(6):352–9, 2006.
Selemon, L.D., and Goldman-Rakic, P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry, 45(1):17–25, 1999.
Selemon, L.D., Rajkowska, G., and Goldman-Rakic, P.S. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry, 52(10):805–18, 1995.
Selemon, L.D., Rajkowska, G., and Goldman-Rakic, P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J Comparative Neurol, 392:402–12, 1998.
Semple, D.M., McIntosh, A.M., and Lawrie, S.M. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol, 19(2):187–94, 2005.
Shenton, M.E., Dickey, C.C., Frumin, M., and McCarley, R.W. A review of MRI findings in schizophrenia. Schizophr Res, 49(1–2):1–52, 2001.
Sowell, E.R., Thompson, P.M., Holmes, C.J., Jernigan, T.L., and Toga, A.W. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci, 2(10):859–61, 1999.
Strakowski, S.M., Delbello, M.P., and Adler, C.M. The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry, 10:105–16, 2005.
Sun, D., Phillips, L., Velakoulis, D., Yung, A., McGorry, P.D., Wood, S.J., van Erp, T.G., Thompson, P.M., Toga, A.W., Cannon, T.D., and Pantelis, C. Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals. Schizophr Res, 108(1–3):85–92, 2009.
Sun, D., Stuart, G.W., Jenkinson, M., Wood, S.J., McGorry, P.D., Velakoulis, D., van Erp, T.G., Thompson, P.M., Toga, A.W., Smith, D.J., Cannon, T.D., and Pantelis, C. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry, 2:1063–1122, 2008.
Thompson, P.M., Mega, M.S., Narr, K.L., Sowell, E.R., Blanton, R.E., and Toga, A.W. Brain image analysis and atlas construction. In: Sonka, M., ed. SPIE Handbook of Medical Image Processing and Analysis: SPIE press, 2000a.
Thompson, P.M., Schwartz, C., Lin, R.T., Khan, A.A., and Toga, A.W. Three-dimensional statistical analysis of sulcal variability in the human brain. J Neurosci, 16:4261–74, 1996a.
Thompson, P.M., Schwartz, C., and Toga, A.W. High-resolution random mesh algorithms for creating a probabilistic 3D surface atlas of the human brain. Psychiatry Res: Neuroimaging, 3:19-34, 1996b.
Thompson, P.M., Vidal, C., Giedd, J.N., Gochman, P., Blumenthal, J., Nicolson, R., Toga, A.W., and Rapoport, J.L. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA, 98(20):11650–5, 2001.
Thompson, P.M., Woods, R.P., Mega, M.S., and Toga, A.W. Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain. Human Brain Mapp, 9:81–92, 2000b.
Van Erp, T.G., Saleh, P.A., Rosso, I.M., Huttunen, M., Lonnqvist, J., Pirkola, T., Salonen, O., Valanne, L., Poutanen, V.P., Standertskjold-Nordenstam, C.G., and Cannon, T.D. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry, 159(9):1514–20, 2002.
Velakoulis, D., Wood, S.J., Wong, M.T., McGorry, P.D., Yung, A., Phillips, L., Smith, D., Brewer, W., Proffitt, T., Desmond, P., and Pantelis, C. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry, 63(2):139–49, 2006.
Watanabe-Galloway, S., and Zhang, W. Analysis of U.S. trends in discharges from general hospitals for episodes of serious mental illness, 1995–2002. Psychiatr Serv, 58(4):496–502, 2007.
Weinberger, D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry, 44(7):660–9, 1987.
Weinberger, D.R., and McClure, R.K. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry, 59:553–8, 2002.
Weiser, M., Reichenberg, A., Grotto, I., Yasvitzky, R., Rabinowitz, J., Lubin, G., Nahon, D., Knobler, H.Y., and Davidson, M. Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study. Am J Psychiatry, 161(7):1219–23, 2004.
Winder, R., Cortes, C.R., Reggia, J.A., and Tagamets, M.A. Functional connectivity in fMRI: A modeling approach for estimation and for relating to local circuits. Neuroimage, 34(3):1093–107, 2007.
Winterer, G., Smolka, M., Samochowiec, J., Ziller, M., Mahlberg, R., Gallinat, J., Rommelspacher, H.P., Herrmann, W.M., and Sander, T. Association of EEG coherence and an exonic GABA(B)R1 gene polymorphism. Am J Med Genet B Neuropsychiatr Genet, 117(1):51–6, 2003.
Wolf, D.H., Gur, R.C., Valdez, J.N., Loughead, J., Elliott, M.A., Gur, R.E., and Ragland, J.D. Alterations of fronto-temporal connectivity during word encoding in schizophrenia. Psychiatry Res, 154(3):221–32, 2007.
Worsley, K.J., Andermann, M., Koulis, T., MacDonald, D., and Evans, A.C. Detecting changes in nonisotropic images. Hum Brain Mapp, 8(2–3):98–101, 1999.
Yung, A.R., and McGorry, P.D. The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophr Bull, 22(2):353–70, 1996.
Yung, A.R., Phillips, L.J., McGorry, P.D., McFarlane, C.A., Francey, S., Harrigan, S., Patton, G.C., and Jackson, H.J. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry, (Supplement), 172(33):14–20, 1998.
Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S.M., McFarlane, C.A., Hallgren, M., and McGorry, P.D. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res, 60(1):21–32, 2003.
Yung, A.R., Phillips, L.J., Yuen, H.P., and McGorry, P.D. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res, 67(2–3):131–42, 2004.
Yung, A.R., Stanford, C., Cosgrave, E., Killackey, E., Phillips, L., Nelson, B., and McGorry, P.D. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res, 84(1):57–66, 2006.
Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell’Olio, M., Francey, S.M., Cosgrave, E.M., Killackey, E., Stanford, C., Godfrey, K., and Buckby, J. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry, 39(11–12):964–71, 2005.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cannon, T.D. (2010). Prediction of Psychosis Through the Prodromal Syndrome. In: Gattaz, W., Busatto, G. (eds) Advances in Schizophrenia Research 2009. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0913-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0913-8_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0912-1
Online ISBN: 978-1-4419-0913-8
eBook Packages: MedicineMedicine (R0)